Inventor

Brian William Dymock

Inventor
Singapore, SG

Overview

26→
Patents
2003–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 26 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry3%
C07CAcyclic or carbocyclic compounds3%
C07KPeptides1%
PatentTitleYear
10,413,550Isoxazole compounds as inhibitors of heat shock proteins201910,308,631Selective anti-cancer compounds20199,718,793'Isoxazole compounds as inhibitors of heat shock proteins'20179,624,242'11-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt'20179,120,815'Solid state forms of macrocyclic kinase inhibitors'20159,062,074'(9E)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt'20158,987,243'11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt'20158,980,873'11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt'20158,642,594'Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors'20148,507,480'Isoxazole compounds as inhibitors of heat shock proteins'20138,487,095'Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms'20138,450,310'Isoxazole compounds as inhibitors of heat shock proteins'20138,163,747'Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms'20127,820,658'Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors'20107,803,831'3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer'20107,728,016'Substituted 5-membered ring compounds and their use'20107,705,027'Isoxazole compounds as inhibitors of heat shock proteins'20107,632,855'Pyrazole compounds as HSP90 inhibitors for the treatment of cancer'20097,612,201'Pyrazole compounds'20097,247,734'3,4-diarylpyrazoles and their use in the therapy of cancer'20077,189,718'Non-nucleoside reverse transcriptase inhibitors'20077,183,296'Anti-HIV pyrazole derivatives'20076,737,429'Pyrrole derivatives'20046,699,887'Anti-HIV pyrazole derivatives'20046,538,015'Anti-HIV pyrazole derivatives'20036,518,293'Anti-HIV imidazolone derivatives'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2007Based in St. Albans, GB· patent location history
2009–2014Patents assigned to CANCER REC TECH LTD (8)· patent assignee history
2009–2014Patents assigned to CANCER RES INST (8)· patent assignee history
2009–2010Patents assigned to VERNALIS CAMBRIDGE LTD (6)· patent assignee history
2009–2014Based in Abingdon, GB· patent location history
2010–2017Based in Abington, GB· patent location history
2012–2019Patents assigned to VERNALIS R&D LTD (7)· patent assignee history
2012–2014Patents assigned to DRYSDALE MARTIN JAMES (5)· patent assignee history
2012–2019Based in Singapore, SG· patent location history
2019Based in Great Abington, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CANCER REC TECH LTD82009–2014
CANCER RES INST82009–2014
VERNALIS R&D LTD72012–2019
VERNALIS CAMBRIDGE LTD62009–2010
DRYSDALE MARTIN JAMES52012–2014
Locations
LocationPatentsSpan
Singapore, SG72012–2019
Abingdon, GB62009–2014
St. Albans, GB62003–2007
Abington, GB42010–2017
Great Abington, GB12019